Clinical trial

Targeted Lung Denervation for Patients With Moderate to Severe COPD

NCT02058459

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-08-04

PhaseNA

Study timeline

Study start (actual)2014-08-04Date precision: day

Registry last updated2022-04-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Chronic Obstructive Pulmonary Disease (COPD)unresolved

Interventions

Holaira™ Lung Denervation System with energy deliveryDEVICE

Holaira™ Lung Denervation System without energy deliveryDEVICE

Sponsors & collaborators

Nuvaira, Inc.lead sponsor

Mapped research locations

LondonUnited Kingdom1 ParisFrance1 BerlinGermany1 BrusselsBelgium1 StrasbourgFrance1 ViennaAustria1 LilleFrance1 LeuvenBelgium1 AmsterdamNetherlands1 EssenGermany1 HeidelbergGermany1 GrenobleFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02058459 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.